Imatinib Completed Phase 3 Trials for Leukemia, Lymphocytic Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00327678Treatment of Acute Lymphoblastic Leukemia (ALL) in Younger Adults